Advanced Medical Solutions Group PLC (AMS) has disclosed that New York-based Glazer Capital, LLC crossed a major shareholding threshold in the company on 5 November 2026. The notification, submitted to the issuer on 6 November 2026, confirms that Glazer Capital holds 8,932,434 shares, representing 4.041043% of Advanced Medical Solutions Group's total shares outstanding. The disclosure was made under standard major holdings notification requirements. Investors in the wound care and surgical specialties group may note the emergence of a new disclosed institutional position above the reporting threshold.

Key Points

  • Advanced Medical Solutions Group PLC (AMS) — medical devices company listed in the UK
  • Glazer Capital, LLC of New York disclosed a 4.041043% direct shareholding following a threshold crossing on 5 November 2026
  • Total shares held: 8,932,434, all held directly with ISIN GB0004536594; no financial instruments reported
  • Investors should watch whether Glazer Capital increases, maintains, or reduces its position in subsequent filings

Glazer Capital Acquires 8,932,434 AMS Shares, Crossing the 4% Disclosure Threshold

The announcement confirms that Glazer Capital, LLC, a discretionary investment manager registered in New York and controlled by Paul J. Glazer, acquired shares in Advanced Medical Solutions Group PLC, triggering a major holdings notification. The threshold was crossed on 5 November 2026, with the issuer notified the following day, 6 November 2026. The holding of 8,932,434 shares equates to 4.041043% of shares outstanding, all held directly in equity. The announcement states no financial instruments, such as options or contracts for difference, form part of the disclosed position.

Glazer Capital Acts as Discretionary Manager for Underlying Client Funds

The notification clarifies that Glazer Capital, LLC is not itself the ultimate beneficial owner of the shares in the conventional sense. Instead, it acts as discretionary investment manager on behalf of a group of investment fund clients, and the filing represents the aggregate holding across those client accounts. The announcement states that Glazer Capital is not controlled by any natural person or legal entity other than through the relationship with Paul J. Glazer, who is identified as the ultimate controlling natural person. No previous notification position is recorded, indicating this is the first time the threshold has been reached or crossed.

Advanced Medical Solutions Group and Its Position in the UK Medical Devices Sector

Advanced Medical Solutions Group PLC is a UK-headquartered medical devices business focused on advanced wound care and surgical products. The company develops and manufactures products including tissue adhesives, haemostats, and wound closure technologies, supplying healthcare markets internationally. With shares listed under ISIN GB0004536594, AMS operates in a sector characterised by regulatory oversight and healthcare procurement cycles. The emergence of a disclosed institutional position from a US-based manager may attract attention from investors monitoring the shareholder register, though the announcement itself does not indicate any intent regarding the direction of the investment.